![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2002 Oxford University Press Effects of mutations at tyrosine 66 and asparagine 123 in the active site pocket of Escherichia coli uracil DNA glycosylase on uracil excision from synthetic DNA oligomers: evidence for the occurrence of long-range interactions between the enzyme and substrate Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560 012, India aTo whom correspondence should be addressed. Phone: +91 80 394 2686; Fax: +91 80 360 2697; Email: varshney/at/mcbl.iisc.ernet.in The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors Received April 4, 2002; Revised May 15, 2002; Accepted May 15, 2002. This article has been cited by other articles in PMC.Abstract Uracil DNA glycosylase (UDG), a highly conserved DNA repair enzyme, excises uracil from DNA. Crystal structures of several UDGs have identified residues important for their exquisite specificity in detection and removal of uracil. Of these, Y66 and N123 in Escherichia coli UDG have been proposed to restrict the entry of non-uracil residues into the active site pocket. In this study, we show that the uracil excision activity of the Y66F mutant was similar to that of the wild-type protein, whereas the activities of the other mutants (Y66C, Y66S, N123D, N123E and N123Q) were compromised ~1000-fold. The latter class of mutants showed an increased dependence on the substrate chain length and suggested the existence of long-range interactions of the substrate with UDG. Investigation of the phosphate interactions by the ethylation interference assay reaffirmed the key importance of the –1, +1 and +2 phosphates (with respect to the scissile uracil) to the enzyme activity. Interestingly, this assay also revealed an additional interference at the –5 position phosphate, whose presence in the substrate had a positive effect on substrate utilisation by the mutants that do not possess a full complement of interactions in the active site pocket. Such long-range interactions may be crucial even for the wild-type enzyme under in vivo conditions. Further, our results suggest that the role of Y66 and N123 in UDG is not restricted merely to preventing the entry of non-uracil residues. We discuss their additional roles in conferring stability to the transition state enzyme–substrate complex and/or enhancing the leaving group quality of the uracilate anion during catalysis. INTRODUCTION Uracil arises in DNA by spontaneous deamination of an inherently unstable base, cytosine, and results in the appearance of G:U mismatches in the genome (1,2). In addition, during DNA replication, DNA polymerases may also erroneously incorporate dUMP opposite adenosine (as an A:U base pair) (2). The G:U mismatches are promutagenic and, if left unrepaired, lead to GC→AT mutations. On the other hand, the occurrence of an A:U base pair in DNA regulatory sequences can impede recognition by the cognate DNA-binding proteins. Therefore, to maintain genomic integrity and safeguard the physiological functions, the cells possess a highly efficient and ubiquitous base excision repair enzyme, uracil DNA glycosylase (UDG) (1). UDGs have pride of place amongst DNA repair enzymes in having a notably high turnover number and strict specificity in admitting only uracil in DNA into the active site pocket. The UDGs also interact with a number of proteins such as the Bacillus subtilis phage-encoded uracil DNA glycosylase inhibitor Ugi and cellular factors such as single-stranded DNA-binding proteins, involved in various vital processes such as DNA replication, repair and recombination (3–5). Subsequently, it was shown that UDGs interact with proliferating cell nuclear antigen (PCNA) and exist as part of a multiprotein complex involving PCNA, polymerase δ, FEN1 and DNA ligase I at the replication foci (6). These observations demonstrate the importance of uracil excision repair in the regions of the genome that become transiently single stranded. Thus, UDGs constitute a remarkably interesting model system to understand the basis of catalytic prowess and specificity associated with protein–DNA and protein– protein interactions. UDGs belong to a highly conserved class of proteins (7,8) and their crystal structures have shown an extraordinary conservation of the overall architecture and active site geometry. The uracil binds in the active site pocket by extensive shape and electrostatic complementarity (8,9). Several hydrogen bonds are established between the conserved UDG residues such as the histidine of the HPSPLS motif [H187 in Escherichia coli UDG (EcoUDG)] and the asparagine of the GVLLLN motif (N123 in EcoUDG) and the 2, 3 and 4 positions of uracil. N123 forms hydrogen bonds with O4 and N3 of uracil, thus effectively restricting cytosine from entering the pocket (10–15). Also, the side chain of the tyrosine of the GQDPYH motif (Y66 in EcoUDG), which is in Van der Waals contact with the C5 position of the uracil ring, excludes thymine, with a methyl group at this position, and the purines, with bulky rings (Fig. (Fig.1).1
In the present study we have carried out mutational analysis of the Y66 and N123 positions in EcoUDG by using a novel in vitro transcription–translation approach for their production. The mutants are highly compromised in their uracil excision activity, and suggest that the roles of these residues in uracil excision are more crucial and significant than just restricting entry of non-uracil bases to the active site pocket. Furthermore, the mutants show an increased dependence on the substrate chain length, suggesting the existence of long-range interactions between the substrate and the enzyme. MATERIALS AND METHODS DNA oligomers and 5′-end-labelling DNA oligomers (SSU4, 5′-AGCUCATAGTTTACCTGAAGAATAT-3′; SSU5, 5′-GAGCUCTGAGGATCCTUTTGGATCCT-3′; SSU9, 5′-CTCAAGTGUAGGCATGCAAGA GCT-3′) were obtained from Ransom Hill Bioscience (USA), 5′-32P-end-labelled and purified on Sephadex G 50 minicolumns (17). For UDG reactions, DNA oligomers were mixed with the radiolabelled counterparts to obtain the desired specific activities. Generation of the constructs used for in vitro transcription–translation of EcoUDG Two pTZ19R-derived laboratory vectors containing the 5′ untranslated region (5′-GGCTGTTGGGGTCCACCACGCCTTCCACCTGCCCCACTGCTTCTTCGCTTCTCTCTTGGAAAGTCCAGTCTCTCCTCGGCTTGCAGGGC-3′) of the human metallothionein-IF gene (18) ligated into the blunt ended SphI (pMTZ1) or HindIII (pMTZ2) site were used for further constructions. The pMTZ2 construct also contained a NcoI site and an ATG codon in a good Kozak context (GGCAACCATGGC). The E.coli ung gene ORF, whose ATG is naturally located within a good Kozak context was cloned as an AluI (position 501, from a limit digest)–EcoRI fragment from pTZUng2 (19) between the HincII and EcoRI sites of pMTZ1, and termed pMTZUng. This construct contains the complete UDG ORF downstream of a T7 RNA polymerase promoter (Fig. (Fig.22
To introduce mutations at the Y66 and N123 positions, the HindIII–EcoRI fragment from pTZUng4S (19) harbouring the relevant portion of the ung gene was subcloned (20) into pTZ18R to yield pTZUng4S′. Single-stranded DNA was prepared from pTZUng4S′ and used for site-directed mutagenesis by a modified Kunkel protocol (21). The mutagenic oligomers containing limited randomisation at one or two positions, 5′-CAGGATCCTT(T/C/G)TCACGGACCG-3′ and 5′-CTGCTACTC(C/G)A(C/G)ACTGTGTTG-3′, were used to generate a limited spectrum of mutations at the Y66 and N123 positions, respectively. DNA sequence analysis identified the presence of the Y66S, Y66C, Y66F, N123E and N123Q mutants. The DNA segments (BamHI–SphI) from these plasmids were directly mobilised into the corresponding sites of pMTZUng, to generate pMTZUngY66C, or into pTrcUng (22), to obtain the corresponding pTrcUng constructs of the Y66S, Y66F, N123E and N123Q mutants, using standard methods (20). Subsequently, the mutant genes from the latter constructs were subcloned into pMTZ2 to yield pMTZUngY66S (or Y66F) and pMTZUngN123E (or N123Q). To obtain pMTZUngN123D, a mutagenic oligomer (5′-GCTACTCGATACTGTGTTG-3′) was used to introduce the mutation into pMTZUng by a megaprimer approach using Pfu DNA polymerase (23). All constructs were confirmed by DNA sequence analysis using Sanger’s dideoxy chain termination method (20). In vitro transcription–translation by non-radioactive/radioactive methods Plasmid DNAs were prepared by the cesium chloride density gradient centrifugation method (20), quantified and used for in vitro transcription–translation reactions in rabbit reticulocyte lysate, according to the supplier’s recommendations (Promega). A typical reaction (50 µl) comprised 25 µl of TNT rabbit reticulocyte lysate, 2 µl of reaction buffer, 1 µl of T7 RNA polymerase, 1 µl of amino acid mixture minus methionine (1 mM), 12.5 µl of [35S]methionine (1000 Ci/mmol, 10 mCi/ml), 40 U RNasin ribonuclease inhibitor and 1 µg DNA template (vector or the UDG gene-containing plasmids). In the non-radioactive translation reactions, 0.5 µl each of the amino acid mixes (–Leu) and (–Met) were used instead of the radiolabelled amino acid. The reaction contents were incubated at 37°C for 2 h. Subsequently, a 2.5 µl aliquot of the reaction was mixed with 10 µl of SDS sample loading dye, heated at 90°C and analysed by 15% SDS–PAGE (24). The gel was stained with Coomassie brilliant blue R-250, destained, dried and subjected to BioImage analysis (Fuji). Similarly, Ugi was in vitro translated in the presence of [35S]methionine using pTZUgi (25), wherein the expression of Ugi was under the control of the T7 RNA polymerase promoter (Fig. (Fig.2)2 Formation of UDG and Ugi complexes from the translates UDG–Ugi complexes were formed by mixing 2.5 µl aliquots (corresponding to ~2500 c.p.m. Ugi) from the supernatants of the heat-treated lysates with 1 µl of the translates programmed with the plasmids harbouring UDG genes in 20 mM Tris–HCl, pH 7.4, for 15 min at room temperature and 15 min on ice. Then, 5 µl of native dye (0.01% bromophenol blue, 10% v/v glycerol and 50 mM Tris–HCl pH 6.8) was added to the reaction mixture and resolved by 15% PAGE at 100 V for 1.5 h (25). The UDG–Ugi complex was detected by BioImage analysis. UDG assays with translates Oligomers (1 pmol, 20 000 c.p.m.) were incubated with the translation reactions (1 µl of the translates or dilutions made in the vector translate) for 10 min (unless indicated otherwise) at 37°C in 10 µl volumes (27). The reactions were terminated with 5 µl of 0.2 N NaOH, heated, dried in vacuo, taken up in 10 µl of loading dye (80% formamide, 0.1% xylene cyanol FF and bromophenol blue and 1 mM Na2EDTA) and half of the contents were electrophoresed on 15% polyacrylamide–8 M urea gels (20) and subjected to BioImage analysis. Phosphate modification interference experiments An aliquot of 1 pmol of high specific activity labelled oligomer SSU9 in 100 µl of 50 mM sodium cacodylate, pH 7.0, 1 mM Na2EDTA was mixed with 100 µl of freshly prepared saturated solution of N-ethyl N-nitrosourea in ethanol and incubated at 50°C for 1 h (28,29). The DNA was ethanol precipitated in the presence of 0.33 M sodium acetate, transferred to liquid nitrogen for 2 min, thawed and centrifuged for 15 min in a microfuge. The pellet was washed with ethanol, dried in vacuo, taken up in 10 µl of water and half of it was subjected to UDG reaction for 5 min at 37°C, with 1 µl of the undiluted or a 1:1000 dilution of the translate containing the N123D or the wild-type UDG, respectively. The reaction was quenched with 5 µl of 0.4 M NaOH at 37°C for 30 min to achieve selective cleavage at the abasic sites, resolved on a 15% polyacrylamide–8 M urea gel and autoradiographed. The bands corresponding to the leftover substrate and the product were cut out, eluted for 6 h in 400 µl of 50 mM Tris–HCl, pH 7.4, and 5 mM Na2EDTA and ethanol precipitated in the presence of 100 µg/ml yeast total RNA. The pellet was washed with 80% alcohol, dried, suspended in 100 µl of piperidine (1 M) and heated at 90°C for 30 min (30). The samples were lyophilised, taken up in 100 µl of water and re-lyophilised. Finally, the residue was taken up in 80% formamide dye and equal counts applied to an 18% polyacrylamide–8 M urea sequencing gel. The control sample was treated similarly except that no UDG was added. RESULTS In vitro synthesis of various UDGs The mutations at Y147 and N204 in human UDG (the equivalents of Y66 and N123 in EcoUDG) have been reported to be cytotoxic (11). Hence, to study the effects of mutations at Y66 and N123 in EcoUDG, we resorted to their production in rabbit reticulocyte lysates (RRL) using an in vitro transcription–translation system (TNT) and the plasmid constructs shown in Figure Figure2.2
The autoradiogram in Figure Figure3A3
Interaction of the translated UDGs with Ugi We used Ugi, a thermostable protein and an exceptional mimic of the DNA substrate which specifically interacts with the conserved class of UDGs (32–35), as a probe to ensure proper folding of the in vitro translated UDGs. However, the presence of an endogenous protein in the RRL which co-migrated with the UDG–Ugi complex on the native gels interfered with the analyses using native Ugi to form complexes with radiolabelled UDG in the in vitro translates (data not shown). Therefore, we radiolabelled Ugi and partially purified it to form complexes with the in vitro translates containing unlabelled proteins. Ugi was produced by in vitro transcription–translation in E.coli S30 lysates (TNT) in the presence of [35S]methionine and, as Ugi remains soluble upon heat treatment, it was enriched in the supernatants by thermal denaturation of most other proteins in the lysates. The [35S]methionine-labelled Ugi–UDG complexes thus formed were analysed by electrophoresis on native gels, wherein free Ugi (9.4 kDa), with a highly acidic pI of 4.2, migrates towards the bottom of the gel and the UDG–Ugi complex (35 kDa), with a pI of 4.9, migrates in the middle of the gel (25). As shown in Figure Figure3B,3 Uracil excision activity of the UDG mutants Assays with the in vitro translates for UDG activity using SSU4, an oligomer harbouring uracil in the fourth position, are shown in Figure Figure4.4
Subsequently, we used yet another substrate, SSU9, having uracil in the ninth position. Y66C, Y66S and N123E showed a detectable but weak uracil excision activity even with SSU9 (Fig. (Fig.4B,4 Uracil excision in mixed substrate reactions The results in Figure Figure44 Wild-type and Y66F UDGs are indifferent to SSU4 and SSU9 To determine if the wild-type and Y66F proteins also preferentially utilised SSU9 over SSU4, the corresponding in vitro translation reactions were diluted up to 10 000-fold and used in the assay. These assays showed that the wild-type and Y66F translates did not discriminate between the two substrates (Fig. (Fig.5B,5 Modification of the backbone phosphates and analysis of the interference in uracil excision Phosphate group-mediated sequence-independent contacts between the nucleic acids and proteins contribute significantly to the stability of the complexes that arise by their specific interactions. Therefore, to assess the role of the backbone phosphates in substrate utilisation by UDG, we modified SSU9 with N-ethyl N-nitrosourea under the conditions which afforded low frequency phosphate ethylation (Fig. (Fig.6B,6
Relative utilisation of SSU9, SSU5 and SSU4 by the wild-type and N123D UDGs To further confirm our interpretation from the ethylation interference assays about the role of the phosphate occupying the –5 position in preferential utilisation of the substrates by UDG mutants, we carried out a triple substrate assay using DNAs with uracil at the fourth (SSU4), fifth (SSU5) or ninth (SSU9) position in equimolar amounts. Notably, 5′ phosphorylated SSU4 lacks the phosphate at the –5 position but the same is included in SSU5 due to the presence of an additional nucleotide upstream of the uracil. As can be seen from the equal intensities of the product bands, translate containing the wild-type UDG utilised all three substrates with similar efficiencies (Fig. (Fig.7,7
DISCUSSION Several high resolution DNA–UDG co-crystal structures have provided an in-depth understanding of the mechanisms that regulate extreme substrate specificity and catalysis by the conserved class of UDGs (10–15). According to a recent study, glycosidic bond cleavage occurs by an autocatalytic step facilitated by interactions between the Ser–Pro loops of the enzyme with the backbone phosphates in the substrate, then a water molecule activated by the highly conserved D64 reacts with the C1′ of the ribose sugar (36). The crystal structures and mutational analyses have also emphasised the role of two other highly conserved residues, Y66 and N123, in conferring strict substrate selectivity for uracil in DNA and in avoiding admission of other bases into the active site pocket (see Introduction). The role of Y66 in restricting entry of thymine or purines was further supported by the discovery of EcoMUG (mismatch-specific glycosylase), which removes U or T from G:U/T and where the topological equivalent of Y66 of EcoUDG is a G residue, which would allow entry of thymine (12,37). In this study, we have carried out mutational analysis of Y66 and N123 in EcoUDG. Similar mutations in human UDGs have been shown to be cytotoxic on account of acquisition of weak thymine/cytosine DNA glycosylase activity (TDG or CDG) (11). At least two of the mutants (Y66C and Y66S) that we attempted to produce in E.coli could also not be expressed (data not shown). Therefore, we resorted to in vitro production of all the UDG mutants in a RRL-based transcription–translation system. Also, while our assays were not specifically designed to detect low CDG/TDG activities, the oligonucleotide-based assay was sensitive in detecting as low as 0.1% of the wild-type activity (Fig. (Fig.5B).5 More importantly, is the role of Y66 and N123 limited only to conferring substrate selectivity? The observation that the Y66S and Y66C mutants showed drastically reduced activity in excision of uracil is inconsistent with the proposed role of Y66 in merely providing a steric block to prevent admittance of thymine or purines into the active site pocket. Had it been just this role, why should there have been a drastic drop in the uracil excision activity of these mutants? The observation that Y66F is similar to the wild-type enzyme in its activity suggests that from a structural view point mutations per se at this position can be tolerated. Thus, we propose that in addition to its role in blocking the entry of non-uracil residues, the Van der Waals interaction (or a possible C-H…π type interaction) that the Y66 (or F66 in the mutant) establishes with the C5 position of the uracil may also facilitate stabilisation of the transition state enzyme–substrate [ES] complex. Such a possibility also provides an explanation for the observation that the utilisation of SSU4 by the Y66S or Y66C mutant was insignificant but increased upon increasing the substrate chain length (SSU9). Most likely the loss of a contribution by Y66 towards stabilisation of the enzyme–substrate complex was partially compensated for by long-range interactions between the substrate and the enzyme (discussed below). Further, as the N123 position donates a hydrogen bond to the O4 of the uracil ring, N123 may also be similarly important in stabilising the transition state enzyme–substrate complex. From another viewpoint, the Asp in the N123D mutant should be in perfect geometry to form a hydrogen bond with the exocyclic 4-NH2 of cytosine. The finding that the CDG activity of the N123D mutant is, at best, less than 0.1% of the UDG activity of the wild-type protein signifies another possible role for N123. It has been proposed that the leaving group quality of the uracilate anion is enhanced by a hydrogen bond from H187 to the O2 group. However, in the native enzyme withdrawal of the electron density towards the amide of N123 will also lead to enhancement of the leaving group quality of the uracilate anion (Scheme (Scheme1A).1
Further, to gain insights into the mechanism of differential utilisation of SSU4 and SSU9 by the UDG mutants, we carried out phosphate ethylation interference assays to study utilisation of SSU9 by the wild-type and the N123D UDG mutant (deficient in hydrogen bonding with the O4 of uracil; Scheme Scheme1B).1 ACKNOWLEDGEMENTS We thank K. Saikrishnan for his help in generating Figure Figure11 REFERENCES 1. Lindahl T., (1982) DNA repair enzymes. Annu. Rev. Biochem., 51, 61–87. [PubMed] 2. Friedberg E.C., Walker,G.C. and Siede,W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC. 3. Mosbaugh D.W., and Bennett,S.E. (1994) Uracil excision repair. Prog. Nucleic Acid Res. Mol. Biol., 48, 315–370. [PubMed] 4. Nagelhus T.A., Haug,T., Singh,K.K., Keshav,K.F., Skorpen,F., Otterlei,M., Bharati,S., Lindmo,T., Benichou,S., Benarous,R. and Krokan,H.E. (1997) A sequence in the N-terminal region of human uracil-DNA glycosylase with homology to XPA interacts with the C-terminal part of the 34-kDa subunit of replication protein A. J. Biol. Chem., 272, 6561–6566. [PubMed] 5. Handa P., Acharya,N. and Varshney,U. (2001) Chimeras between single stranded DNA binding proteins from Escherichia coli and Mycobacterium tuberculosis reveal that their C-terminal domains interact with uracil-DNA glycosylases. J. Biol. Chem., 276, 16992–16997. [PubMed] 6. Otterlei M., Warbrick,E., Nagelhus,T.A., Haug,T., Slupphaug,G., Akbari,M., Aas,P.A., Steinsbekk,K., Bakke,O. and Krokan,H.E. (1999) Post replicative base excision repair in the replication foci. EMBO J., 18, 3834–3844. [PubMed] 7. Aravind L., and Koonin,E.V. (2000) The α/β fold uracil DNA glyosylases: a common origin with diverse fates. Genome Biol., 1, 1–8. [PubMed] 8. Krokan H.E., Standal,R. and Slupphaug,G. (1997) DNA glycosylases in the base excision repair of DNA. Biochem. J., 325, 1–15. [PubMed] 9. Pearl L.H., (2000) Structure and function in the uracil-DNA glycosylase superfamily. Mutat. Res., 460, 165–181. [PubMed] 10. Mol C.D., Arvai,A.S., Slupphaug,G., Kavli,B., Alseth,I., Krokan,H.E. and Tainer,J.A. (1995) Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell, 80, 869–878. [PubMed] 11. Kavli B., Slupphaugh,G., Mol,C.D., Arvai,S.A., Petersen,S.B., Tainer,J.A. and Krokan,H.E. (1996) Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. EMBO J., 15, 3442–3447. [PubMed] 12. Barrett T.E., Savva,R., Panayotou,G., Barlow,T., Brown,T., Jiricny,J. and Pearl,L.H. (1998) Crystal structure of a G:T/U mismatch-specific DNA glycosylase: mismatch recognition by complementary-strand interactions. Cell, 92, 117–129. [PubMed] 13. Savva R., McAuley-Hecht,K., Brown,T. and Pearl,L. (1995) The structural basis of specific base excision repair by uracil-DNA glycosylase. Nature, 373, 487–493. [PubMed] 14. Parikh S.S., Walcher,G., Jones,G.D., Slupphaug,G., Krokan,H.E., Blackburn,G.M. and Tainer,J.A. (2000) Uracil-DNA glycosylase-DNA substrate and product structures: conformational strain promotes catalytic efficiency by coupled stereoelectronic effects. Proc. Natl Acad. Sci. USA, 97, 5083–5088. [PubMed] 15. Parikh S.S., Mol,C.D., Slupphaug,G., Bharati,S., Krokan,H.E. and Tainer,J.A. (1998) Base excision repair initiating revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J., 17, 5214–5226. [PubMed] 16. Sartori A.A., Schar,P., Gibbson,S., Miller,J.H. and Jiricny,J. (2001) Biochemical characterization of uracil processing activities in the hyperthermophilic archaeon Pyrobaculum aerophilum. J. Biol. Chem., 276, 29979–29986. [PubMed] 17. Kumar N.V., and Varshney,U. (1994) Inefficient excision of uracil from loop regions of DNA oligomers by E.coli uracil-DNA glycosylase. Nucleic Acids Res., 18, 3737–3741. [PubMed] 18. Varshney U., Jahroudi,N., Foster,R. and Gedamu,L. (1986) Structure, organization and regulation of human metallothionein IF gene: differential and cell-type-specific expression in response to heavy metals and glucocorticoids. Mol. Cell. Biol., 6, 26–37. [PubMed] 19. Varshney U., Hutcheon,T. and van de Sande,J.H. (1988) Sequence analysis, expression and conservation of Escherichia coli uracil-DNA glycosylase and its gene (ung). J. Biol. Chem., 263, 7776–7784. [PubMed] 20. Sambrook J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 21. Handa P., and Varshney,U. (1998) Rapid and reliable site directed mutagenesis using Kunkel’s approach. Indian J. Biochem. Biophys., 35, 63–66. [PubMed] 22. Handa P., Roy,S. and Varshney,U. (2001) The role of leucine 191 of Escherichia coli uracil DNA glycosylase in forming a stable complex with a substrate mimic, Ugi and in uracil excision from synthetic substrates. J. Biol. Chem., 276, 17324–17331. [PubMed] 23. Picard V., Ersdal-Badju,E., Lu,A. and Bock,S.C. (1994) A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res., 22, 2587–2591. [PubMed] 24. Laemmli U.K., (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685. [PubMed] 25. Roy S., Purnapatre,K., Handa,P., Boyanapalli,M. and Varshney,U. (1998) Use of coupled transcriptional system for consistent overexpression and purification of UDG-Ugi complex and Ugi from E. coli. Protein Expr. Purif., 13, 155–162. [PubMed] 26. Cone R., Bonura,T. and Friedberg,E.C. (1980) Inhibitor of uracil-DNA glycosylase induced by bacteriophage PBS2. Purification and preliminary characterization. J. Biol. Chem., 255, 10354–10358. [PubMed] 27. Kumar N.V., and Varshney,U. (1997) Contrasting effects of single stranded DNA binding protein on the activity of uracil-DNA glycosylase from Escherichia coli towards different DNA substrates. Nucleic Acids Res., 25, 2336–2343. [PubMed] 28. Seibenlist U., and Gilbert,W. (1980) Contacts between Escherichia coli RNA polymerase and an early promoter of phage T7. Proc. Natl Acad. Sci. USA, 77, 122–126. [PubMed] 29. Hendrickson W., and Schleif,R. (1985) A dimer of AraC protein contacts three adjacent major groove regions of the araI DNA site. Proc. Natl Acad. Sci. USA, 82, 3129–3133. [PubMed] 30. Maxam A.M., and Gilbert,W. (1980) Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol., 65, 499–560. [PubMed] 31. Caradonna S., Worrad,D. and Lirette,R. (1987) Isolation of a herpes simplex virus cDNA encoding the DNA repair enzyme, uracil DNA glycosylase. J. Virol., 61, 3040–3047. [PubMed] 32. Mol C.D., Arvai,A.S., Sanderson,R.J., Slupphaug,G., Kavli,B., Krokan,H.E., Mosbaugh,D.W. and Tainer,J.A. (1995) Crystal structure of the human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA. Cell, 82, 701–708. [PubMed] 33. Savva R., and Pearl,L.H. (1995) Nucleotide mimicry in the crystal structure of the uracil-DNA glycosylase-uracil glycosylase inhibitor protein complex. Nature Struct. Biol., 2, 752–755. [PubMed] 34. Ravishankar R., Bidya Sagar,M., Roy,S., Purnapatre,K., Handa,P., Varshney,U. and Vijayan,M. (1998) X-ray analysis of a complex of E.coli uracil-DNA glycosylase (EcUDG) with its proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG. Nucleic Acids Res., 26, 4880–4887. [PubMed] 35. Putnam C.D., Shroyer,M.J.N., Lundquist,A.J., Mol,C.D., Arvai,A.S. and Mosbaugh,D.W. (1999) Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase. J. Mol. Biol., 287, 331–346. [PubMed] 36. Dinner A.R., Blackburn,G.M. and Karplus,M. (2001) Uracil-DNA glycosylase acts by substrate autocatalysis. Nature, 413, 752–755. [PubMed] 37. Gallinari P., and Jiricny,J.A. (1996) A new class of uracil-DNA glycosylase related to human thymine-DNA glycosylase. Nature, 383, 735–738. [PubMed] 38. Varshney U., and van de Sande,J.H. (1991) Specificities and kinetics of uracil excision from uracil containing DNA oligomers by Escherichia coli uracil-DNA glycosylase. Biochemistry, 30, 4055–4061. [PubMed] 39. Slupphaug G., Mol,C.D., Kavli,B., Arvai,A.S., Krokan,H.E. and Tainer,J.A. (1996) A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA. Nature, 384, 87–92. [PubMed] 40. Werner R.M., Jiang,Y.L., Gordley,R.G., Jagadeesh,G.J., Ladner,J.E., Xiao,G., Tordova,M., Gilliland,G.L. and Stivers,J.T. (2000) Stressing out DNA? The contribution of serine-phosphodiester interactions in catalysis by uracil-DNA glycosylase. Biochemistry, 39, 12585–12594. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Annu Rev Biochem. 1982; 51():61-87.
[Annu Rev Biochem. 1982]Prog Nucleic Acid Res Mol Biol. 1994; 48():315-70.
[Prog Nucleic Acid Res Mol Biol. 1994]J Biol Chem. 2001 May 18; 276(20):16992-7.
[J Biol Chem. 2001]EMBO J. 1999 Jul 1; 18(13):3834-44.
[EMBO J. 1999]Genome Biol. 2000; 1(2):comment1002.1-1002.2.
[Genome Biol. 2000]Biochem J. 1997 Jul 1; 325 ( Pt 1)():1-16.
[Biochem J. 1997]Mutat Res. 2000 Aug 30; 460(3-4):165-81.
[Mutat Res. 2000]Cell. 1995 Mar 24; 80(6):869-78.
[Cell. 1995]EMBO J. 1998 Sep 1; 17(17):5214-26.
[EMBO J. 1998]Nucleic Acids Res. 1994 Sep 11; 22(18):3737-41.
[Nucleic Acids Res. 1994]Mol Cell Biol. 1986 Jan; 6(1):26-37.
[Mol Cell Biol. 1986]J Biol Chem. 1988 Jun 5; 263(16):7776-84.
[J Biol Chem. 1988]J Biol Chem. 1988 Jun 5; 263(16):7776-84.
[J Biol Chem. 1988]Indian J Biochem Biophys. 1998 Apr; 35(2):63-6.
[Indian J Biochem Biophys. 1998]J Biol Chem. 2001 May 18; 276(20):17324-31.
[J Biol Chem. 2001]Nucleic Acids Res. 1994 Jul 11; 22(13):2587-91.
[Nucleic Acids Res. 1994]Nature. 1970 Aug 15; 227(5259):680-5.
[Nature. 1970]Protein Expr Purif. 1998 Jul; 13(2):155-62.
[Protein Expr Purif. 1998]J Biol Chem. 1980 Nov 10; 255(21):10354-8.
[J Biol Chem. 1980]Protein Expr Purif. 1998 Jul; 13(2):155-62.
[Protein Expr Purif. 1998]Nucleic Acids Res. 1997 Jun 15; 25(12):2336-43.
[Nucleic Acids Res. 1997]Proc Natl Acad Sci U S A. 1980 Jan; 77(1):122-6.
[Proc Natl Acad Sci U S A. 1980]Proc Natl Acad Sci U S A. 1985 May; 82(10):3129-33.
[Proc Natl Acad Sci U S A. 1985]Methods Enzymol. 1980; 65(1):499-560.
[Methods Enzymol. 1980]EMBO J. 1996 Jul 1; 15(13):3442-7.
[EMBO J. 1996]J Virol. 1987 Oct; 61(10):3040-7.
[J Virol. 1987]Cell. 1995 Sep 8; 82(5):701-8.
[Cell. 1995]J Mol Biol. 1999 Mar 26; 287(2):331-46.
[J Mol Biol. 1999]Protein Expr Purif. 1998 Jul; 13(2):155-62.
[Protein Expr Purif. 1998]Cell. 1995 Mar 24; 80(6):869-78.
[Cell. 1995]EMBO J. 1998 Sep 1; 17(17):5214-26.
[EMBO J. 1998]Nature. 2001 Oct 18; 413(6857):752-5.
[Nature. 2001]Cell. 1998 Jan 9; 92(1):117-29.
[Cell. 1998]Nature. 1996 Oct 24; 383(6602):735-8.
[Nature. 1996]EMBO J. 1996 Jul 1; 15(13):3442-7.
[EMBO J. 1996]Biochemistry. 1991 Apr 23; 30(16):4055-61.
[Biochemistry. 1991]Nature. 1996 Nov 7; 384(6604):87-92.
[Nature. 1996]Biochemistry. 2000 Oct 17; 39(41):12585-94.
[Biochemistry. 2000]Proc Natl Acad Sci U S A. 1980 Jan; 77(1):122-6.
[Proc Natl Acad Sci U S A. 1980]